Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer-aided molecular design III: 2.5D indices for the discovery of antibacterials.
The present work continues our series on the use of MARCH-INSIDE molecular descriptors (parts I and II: J Mol Mod 8:237-245, [2002] and 9:395-407, [2003]). These descriptors encode information pertaining to the distribution of electrons in the molecule based on a simple stochastic approach to the idea of electronegativity equalization (Sanderson's principle). Here, 3D-MARCH-INSIDE molecular descriptors for 667 organic compounds are used as input for a linear discriminant analysis. This 2.5D-QSAR model discriminates between antibacterial compounds and non-antibacterial ones with 92.9% accuracy in training sets. On the other hand, the model classifies 94.0% of the compounds in test set correctly. Additionally, the present QSAR performs similar-to-better than other methods reported elsewhere. Finally, the discovery of a novel compound illustrates the use of the method. This compound, 2-bromo-3-(furan-2-yl)-3-oxo-propionamide has MIC50 of 6.25 and 12.50 microg/mL against Pseudomonas aeruginosa ATCC 27853 and Escherichia coli ATCC 27853, respectively while ampicillin, amoxicillin, clindamycin, and metronidazole have, for instance, MIC50 values higher than 250 mug/mL against E. coli. Consequently, the present method may becomes a useful tool for the in silico discovery of antibacterials.
González-Díaz
Humberto
H
Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, 15782, Spain. humbertogd@uclv.edu.cu
Torres-Gómez
Luis A
LA
Guevara
Yaima
Y
Almeida
Manuel S
MS
Molina
Reinaldo
R
Castañedo
Nilo
N
Santana
Lourdes
L
Uriarte
Eugenio
E
D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000494:pharmacology; D017076:Computer-Aided Design; D015195:Drug Design; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development; D008390:Markov Chains; D008826:Microbial Sensitivity Tests; D008958:Models, Molecular; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000254:growth & development; D021281:Quantitative Structure-Activity Relationship
D000900:Anti-Bacterial Agents
Bull Math Biol. 2004 Sep;66(5):1285-311
15294426
J Chem Inf Comput Sci. 2001 Jan-Feb;41(1):147-58
11206367
J Mol Model. 2003 Dec;9(6):395-407
13680309
Chem Res Toxicol. 2003 Oct;16(10):1318-27
14565773
J Chem Inf Comput Sci. 1998 May-Jun;38(3):445-9
9611784
Antimicrob Agents Chemother. 2003 Mar;47(3):923-31
12604523
Science. 1988 Jun 3;240(4857):1285-93
3287615
Chem Rev. 1996 May 9;96(3):1027-1044
11848779
Bioorg Med Chem Lett. 2003 Aug 18;13(16):2699-702
12873497
J Med Chem. 2003 Apr 10;46(8):1390-407
12672239
Bioinformatics. 2003 Nov 1;19(16):2079-87
14594713
Comput Biol Chem. 2003 Jul;27(3):217-27
12927098
Antimicrob Agents Chemother. 2003 Apr;47(4):1443-6
12654689
J Chem Inf Comput Sci. 2002 Jul-Aug;42(4):869-78
12132888
J Mol Model. 2002 Aug;8(8):237-45
12324800
J Chem Inf Comput Sci. 2003 Mar-Apr;43(2):422-8
12653504
Science. 1951 Dec 21;114(2973):670-2
17770191
Bull Math Biol. 2003 Nov;65(6):991-1002
14607285
J Comput Aided Mol Des. 1996 Dec;10(6):513-20
9007685
J Chem Inf Comput Sci. 2004 Mar-Apr;44(2):515-21
15032531
Proteins. 2004 Sep 1;56(4):715-23
15281125
J Chem Inf Comput Sci. 2001 Mar-Apr;41(2):387-93
11277727
J Chem Inf Comput Sci. 2003 Jul-Aug;43(4):1192-9
12870911